{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:49:23Z","timestamp":1795034963352,"version":"4.10.2"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"12","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["within the CRC\/Transregio 205\/1 \u201cThe Adrenal: Ce"],"award-info":[{"award-number":["within the CRC\/Transregio 205\/1 \u201cThe Adrenal: Ce"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Else Kr\u00f6ner-Fresenius Stiftung in support of the German Conn\u2019s Registry-Else-Kr\u00f6ner Hyperaldosteronism Registry","award":["2013_A182,2015_A171 ,2019_A104 to MR"],"award-info":[{"award-number":["2013_A182,2015_A171 ,2019_A104 to MR"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Context Primary aldosteronism (PA) represents the most frequent cause of\n                    endocrine arterial hypertension. PA is also common in patients with mild forms\n                    of hypertension and normokalemia.<\/jats:p><jats:p>\n          Objective To identify the prevalence of PA in newly diagnosed hypertensive\n                    patients in primary care in Southern Germany.<\/jats:p><jats:p>\n          Patients and methods Newly diagnosed hypertensive patients in 27 primary\n                    care centers in Munich agreed to participate in the study. Patients were\n                    screened for PA using the aldosterone-to-renin ratio (ARR). In case of elevated\n                    ARR, confirmation testing was performed. After the diagnosis of PA, subtype\n                    differentiation and subsequent therapy of PA were initiated.<\/jats:p><jats:p>\n          Results A total of 235 patients with newly discovered arterial\n                    hypertension were initially screened for PA. Among these, 35 were excluded\n                    because the medication indicated pre-existing treated arterial hypertension or\n                    they were on interfering antihypertensive medication. At the first screening,\n                    2.0% of the patients had hypokalemia. Of the 200 patients with newly\n                    discovered arterial hypertension, 42 had an elevated ARR. The incidence of the\n                    presence of hypokalemia did not differ according to normal or pathological ARR.\n                    Nine patients (21%) did not show up for further testing and were lost to\n                    follow-up, and 33 patients underwent a saline infusion test. Of these, 11\n                    patients were diagnosed with PA, leading to at least 5.5% prevalence of\n                    PA in the collective. None of the diagnosed PA patients was hypokalemic at\n                    screening.<\/jats:p><jats:p>\n          Conclusion A 5.5% prevalence of PA was observed in our data of\n                    untreated newly diagnosed patients with hypertension.<\/jats:p>","DOI":"10.1055\/a-1938-4242","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:03:07Z","timestamp":1662591787000},"page":"801-805","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive\n                    Patients in Primary Care"],"prefix":"10.1055","volume":"130","author":[{"given":"Evelyn","family":"Asbach","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der\n                    Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Kellnar","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik I, Klinikum der\n                    Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Bekeran","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der\n                    Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schelling","sequence":"additional","affiliation":[{"name":"Gemeinschaftspraxis Martinsried, R\u00f6ntgenstr.\n                    Planegg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der\n                    Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der\n                    Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.beem.2019.101365","article-title":"Prevalence, diagnosis and outcomes of treatment for primary aldosteronism","volume":"34","author":"Y Yang","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared\n                    with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"S Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and\n                    treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"J W Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fendo.2020.00121","article-title":"Long-term mortality for patients of primary aldosteronism compared with\n                    essential hypertension: A systematic review and meta-analysis","volume":"11","author":"Z Meng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary\n                    aldosteronism: A retrospective cohort study","volume":"6","author":"G L Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism\n                    patients at long term","volume":"71","author":"G P Rossi","year":"2018","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MED.0000000000000408","article-title":"Primary aldosteronism in the primary care setting","volume":"25","author":"F Buffolo","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: Uptake by primary care physicians in\n                    Europe","volume":"34","author":"P Mulatero","year":"2016","journal-title":"J Hypertens"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the\n                    task force for the management of arterial hypertension of the European Society\n                    of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"G Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism:\n                    An endocrine society clinical practice guideline","volume":"93","author":"J W Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary\n                    aldosteronism","volume":"98","author":"E Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2012-2234","article-title":"Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary\n                    aldosteronism after adrenalectomy","volume":"97","author":"E Fischer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is\n                    useful in centers with low success rates","volume":"165","author":"M J Betz","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: Evaluation of the German Conn\u2019s registry","volume":"57","author":"O Vonend","year":"2011","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/diagnostics10080545","article-title":"Aldosterone-mediated sodium retention is reflected by the Serum Sodium to\n                    Urinary Sodium to (Serum Potassium)(2) to Urinary Potassium (SUSPPUP) index","author":"E Kanaan","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: A cohort\n                    study","volume":"75","author":"G Jaffe","year":"2020","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4873.","article-title":"Testing for primary aldosteronism and mineralocorticoid receptor antagonist use\n                    among U.S. veterans: A retrospective cohort study","author":"J B Cohen","year":"2020","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in\n                    primary care practice","volume":"69","author":"S Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"L Mosso","year":"2003","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.hyp.0000040261.30455.b6","article-title":"Hyperaldosteronism among black and white subjects with resistant\n                    hypertension","volume":"40","author":"D A Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125\n                    hypertensive patients","volume":"48","author":"G P Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: A\n                    systematic review and meta-regression analysis","volume":"101","author":"S C Kayser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"F Buffolo","year":"2017","journal-title":"Horm Metab Res"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1938-4242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:57:33Z","timestamp":1671325053000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1938-4242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,15]]},"published-print":{"date-parts":[[2022,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1938-4242","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,7]]},"published":{"date-parts":[[2022,9,7]]}}}